Lü BY - Search Results

1

[Flow cytometry-pathology combined study of breast cancer].

Yu ZY, Yu JM, Wu TH, Zhuo PY, Wang SF, Li M, Zhang X, Lü BY, Liu YB. Yu ZY, et al. Among authors: lu by. Zhonghua Zhong Liu Za Zhi. 2005 Jul;27(7):420-2. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16188128 Chinese.

2

[Brenner tumor of the vagina: report of a case].

Ge WS, Lu B, Yang HY, Li MP. Ge WS, et al. Zhonghua Bing Li Xue Za Zhi. 2024 Sep 8;53(9):953-955. doi: 10.3760/cma.j.cn112151-20240531-00358. Zhonghua Bing Li Xue Za Zhi. 2024. PMID: 39231753 Chinese.

3

Successful treatment of small bowel phytobezoar using double balloon enterolithotripsy combined with sequential catharsis: A case report.

Lu BY, Zeng ZY, Zhang DJ. Lu BY, et al. World J Radiol. 2024 Nov 28;16(11):683-688. doi: 10.4329/wjr.v16.i11.683. World J Radiol. 2024. PMID: 39635309 Free PMC article.

4

Circulating tumor-reactive KIR⁺CD8⁺ T cells suppress anti-tumor immunity in patients with melanoma.

Lu BY, Lucca LE, Lewis W, Wang J, Nogueira CV, Heer S, Rayon-Estrada V, Axisa PP, Reeves SM, Buitrago-Pocasangre NC, Pham GH, Kojima ML, Wei W, Aizenbud L, Bacchiocchi A, Zhang L, Walewski JJ, Chiang V, Olino K, Clune J, Halaban R, Kluger Y, Coyle AJ, Kisielow J, Obermair FJ, Kluger HM, Hafler DA. Lu BY, et al. Nat Immunol. 2025 Jan;26(1):82-91. doi: 10.1038/s41590-024-02023-4. Epub 2024 Nov 28. Nat Immunol. 2025. PMID: 39609626

5

Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti-CTLA-4 in renal cell carcinoma.

Schoenfeld DA, Djureinovic D, Su DG, Zhang L, Lu BY, Kamga L, Mann JE, Huck JD, Hurwitz M, Braun DA, Jilaveanu L, Ring AM, Kluger HM. Schoenfeld DA, et al. Among authors: lu by. JCI Insight. 2024 Nov 19:e184545. doi: 10.1172/jci.insight.184545. Online ahead of print. JCI Insight. 2024. PMID: 39561007 Free article.

6

[Genetic Analysis of Thalassemia in Children in Liuzhou of Guangxi Zhuang Autonomous Region].

Lu BY, Yuan DJ, Huang LS, Qin LQ, Zhong QY. Lu BY, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Oct;32(5):1490-1495. doi: 10.19746/j.cnki.issn.1009-2137.2024.05.029. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024. PMID: 39479837 Chinese.

7

Upadacitinib for refractory ulcerative colitis with primary nonresponse to infliximab and vedolizumab: A case report.

Xu X, Jiang JW, Lu BY, Li XX. Xu X, et al. Among authors: lu by. World J Clin Cases. 2024 Mar 26;12(9):1685-1690. doi: 10.12998/wjcc.v12.i9.1685. World J Clin Cases. 2024. PMID: 38576732 Free PMC article.

8

Providing 0.1 Full-Time Equivalent (FTE) Support to Fellowship Core Faculty Improves Faculty Involvement in Fellowship Education and Recruitment.

Butt A, Christian J, Kress A, Lu BY, Hurwitz ME, Goldberg SB, Podoltsev NA, Gilkes L, Lee AI. Butt A, et al. Among authors: lu by. J Cancer Educ. 2024 Jun;39(3):325-334. doi: 10.1007/s13187-024-02414-z. Epub 2024 Mar 2. J Cancer Educ. 2024. PMID: 38430454

9

Impact of psychiatric social workers on length of stay in psychiatric emergency service.

Lu BY, Onoye JM, Kim KM, Toohey TP, Takeshita J. Lu BY, et al. Acad Emerg Med. 2024 Apr;31(4):401-403. doi: 10.1111/acem.14808. Epub 2023 Oct 16. Acad Emerg Med. 2024. PMID: 37739801 No abstract available.

10

Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy?

Lu BY, Goldberg SB. Lu BY, et al. J Clin Oncol. 2023 Oct 1;41(28):4462-4464. doi: 10.1200/JCO.23.01323. Epub 2023 Aug 21. J Clin Oncol. 2023. PMID: 37603819 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters